Name | CaV1.3 antagonist-1 |
---|
Description | CaV1.3 antagonist-1 is a potent and highly selective CaV1.3 L-type calcium channel (LTCC) antagonist with an IC50 of 1.7 μM. CaV1.3 antagonist-1 inhibits CaV1.3 LTCC >600-fold more potently than CaV1.2 LTCC. CaV1.3 antagonist-1, a cyclopentyl derivative, has the potential for Parkinson's disease research[1]. |
---|---|
Related Catalog | |
Target |
CaV1.3:1.7 μM (IC50) |
In Vitro | CaV1.3 antagonist-1 (Compound 8; 5 μM) exhibits 31.2% and 4.4% inhibition for CaV1.3 and CaV1.2 channel current in HEK293 cells, respectively. This correlates with the results of the FLIPR assay[1]. |
References |
Molecular Formula | C17H19ClN2O3 |
---|---|
Molecular Weight | 334.80 |